1543 Results for "

ADC Linker

" in MedChemExpress (MCE) Product Catalog:
Products (1543)

1543 Results for "ADC Linker" in MCE Product Catalog:

97
97 Publications Verification
製品番号: HY-15575
CAS 番号: 646502-53-6
純度:  99.94%
別名: MC-Val-Cit-PAB-MMAE; mc-vc-PAB-MMAE; Vedotin
VcMMAE (mc-vc-PAB-MMAE) is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE, a tubulin inhibitor), linked via the lysosomally cleavable dipeptide, valine-citrulline (vc).
loading...
    loading...
32
32 Cited Publications
製品番号: HY-13631E
CAS 番号: 1599440-13-7
純度:  99.94%
別名: MC-GGFG-DXD
研究分野:  

Cancer

Deruxtecan is an ADC drug-linker conjugate composed of an DX-8951 derivative (DXd) and a maleimide-GGFG peptide linker, used for synthesizing Trastuzumab deruxtecan (HY-138298A) and Patritumab deruxtecan (HY-P99813) .
loading...
    loading...
28
28 Cited Publications
製品番号: HY-19792
CAS 番号: 139504-50-0
別名: DM1; Maytansinoid DM1
研究分野:  

Cancer

Mertansine (DM1) is a microtubulin inhibitor and is an antibody-conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor-specific delivery. Mertansine can be attached to a monoclonal antibody with a linker to create an antibody-drug conjugate (ADC) .
loading...
    loading...
12
12 Cited Publications
製品番号: HY-101070
CAS 番号: 1228105-51-8
純度:  99.23%
別名: DM1-SMCC
研究分野:  

Cancer

SMCC-DM1 (DM1-SMCC) is a agent-linker conjugate composed of a potent microtubule-disrupting agent DM1 and a linker SMCC to make antibody agent conjugate (ADC) .
loading...
    loading...
11
11 Cited Publications
製品番号: HY-132254
CAS 番号: 1491917-83-9
純度:  99.13%
別名: IMMU-132
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. The antibody portion is Sacituzumab (HY-P99045), and the drug-linker conjugate for ADC is CL2A-SN-38 (HY-128946). Sacituzumab govitecan shows anticancer activity .
loading...
    loading...
11
11 Cited Publications
製品番号: HY-132254A
CAS 番号: 1491917-83-9
純度:  96.61%
別名: IMMU-132 (solution)
Sacituzumab govitecan (IMMU-132) is an antibody-drug conjugate (ADC) targeting Trop-2 for delivery of SN-38. The antibody portion is Sacituzumab (HY-P99045), and the drug-linker conjugate for ADC is CL2A-SN-38 (HY-128946). Sacituzumab govitecan shows anticancer activity .
loading...
    loading...
9
9 Cited Publications
製品番号: HY-138298
CAS 番号: 1826843-81-5
純度:  98.90%
別名: T-DXd (solution); DS-8201 (solution); DS-8201a (solution)
Trastuzumab deruxtecan (T-DXd; DS-8201a) (solution) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer .
loading...
    loading...
9
9 Cited Publications
製品番号: HY-138298A
CAS 番号: 1826843-81-5
純度:  99.58%
別名: T-DXd; DS-8201; DS-8201a
Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer .
loading...
    loading...
8
8 Cited Publications
製品番号: HY-42973
CAS 番号: 1353016-71-3
Target:  

ADC Linkers

研究分野:  

Cancer

DBCO-NHS ester is a non-cleavable ADC linker used in the synthesis of antibody-drug conjugates (ADCs) . DBCO-NHS ester is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
loading...
    loading...
8
8 Cited Publications
製品番号: HY-15578
CAS 番号: 863971-19-1
純度:  99.96%
別名: Maleimidocaproyl monomethylauristatin F
研究分野:  

Cancer

McMMAF (Maleimidocaproyl monomethylauristatin F) is an active molecule linker for ADC, made by coupling the powerful microtubule inhibitor Monomethyl auristatin F (MMAF) (HY-15579) with the protecting group maleimidocaproyl. McMMAF can be conjugated with anti-BCMA antibodies to form J6M0-mcMMAF, promoting apoptosis and inhibiting tumor growth .
loading...
    loading...
7
7 Cited Publications
製品番号: HY-P9921A
CAS 番号: 1018448-65-1
別名: Ado-Trastuzumab emtansine (solution); PRO132365 (solution); T-DM 1 (solution)
Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1 (derivative of maytansine), and the drug-linker conjugate for ADC is SMCC-DM1 (HY-101070). Trastuzumab emtansine can be used for the research of advanced breast cancer .
loading...
    loading...
7
7 Cited Publications
製品番号: HY-128952
CAS 番号: 1595275-62-9
純度:  98.10%
別名: SG3249
Tesirine (SG3249) is an antibody-drug conjugate (ADC) pyrrolobenzodiazepine (PBD) dimer payload. Tesirine combines potent antitumor activity with desirable physicochemical properties such as favorable hydrophobicity and improved conjugation characteristics. SG3199 (HY-101161) is the released warhead component of the ADC payload Tesirine. SG3199 retains picomolar activity in a panel of cancer cell lines. PBD dimers are highly efficient DNA minor groove cross-linking agents with potent cytotoxicity .
loading...
    loading...
7
7 Cited Publications
製品番号: HY-128946
CAS 番号: 1279680-68-0
純度:  99.07%
CL2A-SN-38 is a agent-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody agent conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types. CL2A-SN-38 uses hydrolyzable linker to deliver active agents within tumor cells and in the tumor microenvironment, resulting in bystander effects .
loading...
    loading...
6
6 Cited Publications
製品番号: HY-20336
CAS 番号: 159857-81-5
別名: Maleimidocaproyl-L-valine-L-citrulline-p-aminobenzyl alcohol p-nitrophenyl carbonate
Target:  

ADC Linkers

Mc-Val-Cit-PABC-PNP is a cathepsin cleavable linker for antibody-drug conjugates (ADCs) which couples the antibody element to the effecting compound. Mc-Val-Cit-PABC-PNP can be used in the synthesis of ADCs .
loading...
    loading...
5
5 Cited Publications
製品番号: HY-114697
CAS 番号: 79642-50-5
純度:  98.13%
別名: Disuccinimidyl glutarate
研究分野:  

Inflammation/Immunology

DSG Crosslinker is an amine-reactive and noncleavable protein crosslinker. DSG Crosslinker enables stable protein-protein, peptide, and biomolecule conjugation.
loading...
    loading...
5
5 Cited Publications
製品番号: HY-100216
CAS 番号: 68181-17-9
純度:  99.14%
別名: SPDP CrossLinker; Py-ds-Prp-OSu
Target:  

ADC Linkers

研究分野:  

Cancer

SPDP (SPDP Crosslinker) is a short-chain crosslinker for amine-to-sulfhydryl conjugation via NHS-ester and pyridyldithiol reactive groups that form cleavable (reducible) disulfide bonds with cysteine sulfhydryls. It is a glutathione cleavable ADC linker used for the antibody-drug conjugates (ADCs) .
loading...
    loading...
5
5 Cited Publications
製品番号: HY-P9985
CAS 番号: 2136633-23-1
別名: RC48
研究分野:  

Cancer

Disitamab vedotin (RC48) is an antibody-drug conjugate (ADC) comprising a monoclonal antibody against human epidermal growth factor receptor 2 (HER2) conjugated via a cleavable linker to the cytotoxic agent Monomethyl auristatin E (MMAE) (HY-15162), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Disitamab vedotin enhances antitumor immunity .
loading...
    loading...
5
5 Cited Publications
製品番号: HY-112786
CAS 番号: 863971-17-9
純度:  98.16%
別名: Vc-MMAF
研究分野:  

Cancer

MC-Val-Cit-PAB-MMAF (Vc-MMAF) is a drug-linker conjugate for ADC by using the tubulin inhibitor, MMAF (HY-15579), linked via cathepsin cleavable MC-Val-Cit-PAB (HY-78738). MC-Val-Cit-PAB-MMAF shows antitumor activity .
loading...
    loading...
4
4 Cited Publications
製品番号: HY-100874
CAS 番号: 3046395-46-1
純度:  98.56%
研究分野:  

Cancer

N3-PEG3-vc-PAB-MMAE is a synthesized agent-linker conjugate for ADC that incorporates the MMAE (a tubulin inhibitor ) and 3-unit PEG linker. N3-PEG3-vc-PAB-MMAE shows potent antitumor activity. N3-PEG3-vc-PAB-MMAE is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
loading...
    loading...
3
3 Cited Publications
製品番号: HY-111012
CAS 番号: 2754384-60-4
純度:  99.60%
研究分野:  

Cancer

DBCO-(PEG)3-VC-PAB-MMAE is a agent-linker conjugate for ADC. DBCO-(PEG)3-VC-PAB-MMAE is made by Monomethyl auristatin E (HY-15162) conjugats to DBCO-(PEG)3-vc-PAB linker. DBCO-(PEG)3-VC-PAB-MMAE can be used for the research of cancer . DBCO-(PEG)3-VC-PAB-MMAE is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
loading...
    loading...